The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
Elevance Health's financial outlook for FY 2025 anticipates GAAP diluted earnings per share (EPS) to be in the range of $30.40 to $31.10 and adjusted diluted EPS to be in the range of $34.15 to $34.85 ...
FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.
Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.
Newsweek sought email comment on Monday from UnitedHealth and two other companies named in the lawsuit—CVS Health's CVS Caremark ... the CEO of UnitedHealth Group's insurance wing ...
Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...
Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...
The home health ... CVS' rival UnitedHealth, which according to media reports was also interested in Signify, has made a separate move to bulk up into this area via a $5.4 billion deal to buy LHC ...
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...
The company said Thursday that Tim Noel will be CEO of UnitedHealthcare, replacing Brian Thompson, who was killed in New York ...